Skip to main content
. 2013 Dec 23;13:173. doi: 10.1186/1471-230X-13-173

Figure 2.

Figure 2

The relationship between combined WRN, SULF2 promoter methylation and the sensitivity for gastric cancer to irinotecan. W-S-: WRN unmethylation、SULF2 unmethylation; W + S-: WRN methylation、SULF2 unmethylation. W-S + : WRN unmethylation、SULF2 methylation; W + S+: WRN methylation、SULF2 methylation.